Sapiens International (SPNS) has had the highest return between September 30, 2025 and December 29, 2025 by a mid-cap US stock, returning 32,334.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Sapiens International (SPNS) | 9/30/2025 - 12/29/2025 | 32,334.32% |
Praxis Precision Medicines (PRAX) | 9/30/2025 - 12/29/2025 | 490.16% |
Terns Pharmaceuticals (TERN) | 9/30/2025 - 12/29/2025 | 433.42% |
Hycroft Mining (HYMC) | 9/30/2025 - 12/29/2025 | 277.6% |
PACS (PACS) | 9/30/2025 - 12/29/2025 | 184.4% |
Cogent Biosciences (COGT) | 9/30/2025 - 12/29/2025 | 171.4% |
Olema Pharmaceuticals (OLMA) | 9/30/2025 - 12/29/2025 | 168.76% |
Nuvation Bio (NUVB) | 9/30/2025 - 12/29/2025 | 168.05% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 9/30/2025 - 12/29/2025 | 166.01% |
Wave Life Sciences (WVE) | 9/30/2025 - 12/29/2025 | 149.79% |
Cidara Therapeutics (CDTX) | 9/30/2025 - 12/29/2025 | 132.94% |
Vicor (VICR) | 9/30/2025 - 12/29/2025 | 131.84% |
Belite Bio Inc ADR (BLTE) | 9/30/2025 - 12/29/2025 | 126.42% |
Sandisk (SNDK) | 9/30/2025 - 12/29/2025 | 114.07% |
Victoria's Secret (VSCO) | 9/30/2025 - 12/29/2025 | 111.99% |
Central Puerto (CEPU) | 9/30/2025 - 12/29/2025 | 109.29% |
BBVA Banco Frances SA ADR (BBAR) | 9/30/2025 - 12/29/2025 | 107.62% |
Banco Macro SA B ADR (BMA) | 9/30/2025 - 12/29/2025 | 106.55% |
Arrowhead Pharmaceuticals (ARWR) | 9/30/2025 - 12/29/2025 | 105.49% |
Spyre Therapeutics (SYRE) | 9/30/2025 - 12/29/2025 | 99.39% |
Celcuity LLC (CELC) | 9/30/2025 - 12/29/2025 | 95.53% |
Immunome (IMNM) | 9/30/2025 - 12/29/2025 | 91.83% |
Apogee Therapeutics, Inc Common Stock (APGE) | 9/30/2025 - 12/29/2025 | 91.19% |
Grupo Financiero Galicia SA ADR (GGAL) | 9/30/2025 - 12/29/2025 | 88.32% |
Vera Therapeutics (VERA) | 9/30/2025 - 12/29/2025 | 80.42% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
